Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07134543

Using the Smart Underwear Device to Determine a Baseline of Flatus Activity Normalized to Fiber Intake

The goal of this observational study is to quantify the typical frequency of flatulence in healthy adults, normalized by fiber intake, using the Smart Underwear device. The study will enroll a maximum of 500 adults across the United States who will wear the device for three consecutive days while continuing their usual daily activities.

The main questions it aims to answer are:

* What is the average frequency of flatus events in a general adult population? * How does dietary fiber intake influence flatus frequency and microbiome activity?

Researchers will collect gas sensor data from the Smart Underwear device alongside dietary information logged in a mobile app to assess the relationship between diet and microbiome activity.

Participants will:

* Complete an online eligibility survey, consent form, and background questionnaire. * Wear the Smart Underwear device for at least 12 hours per day for three consecutive days. * Log all meals with photos using a custom smartphone app. * Complete a short post-wear survey about device comfort and usability.

All study procedures will be conducted remotely. Data will be analyzed in de-identified form to evaluate baseline flatulence patterns, normalized to fiber intake, in the general adult population.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Bioscience Research Building, College Park, Maryland, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years old or older
  • Lives in the US
  • Is not pregnant or lactating
  • Is willing to wear the Smart Underwear device as instructed in the study procedures

Exclusion criteria

  • Younger than 18 years old
  • Lives outside the US
  • Is pregnant or lactating
  • Is not willing to wear the Smart Underwear device as instructed in the study procedures

Treatment and study plan

Primary outcomes

  1. Microbiome Activity Index

    Time frame: 12 hours each day for 3 days

    The Microbiome Activity Index is a composite measure reflecting gut microbiome activity, calculated from both flatus frequency and hydrogen gas concentration. The index uses the absolute value of the first derivative of the hydrogen sensor signal to better capture flatus intensity, reduce baseline noise, and mitigate sensor saturation at high hydrogen levels. This composite approach ensures a more accurate representation of gut microbiome activity than relying on flatus count or hydrogen concentration alone. Data are collected using a wearable device ("Smart Underwear") and uploaded to the Human Flatus Atlas app.

Secondary outcomes

  1. Total flatus count

    Time frame: 12 hours each day for 3 days

    The total number of flatus events detected by the wearable device. Detection is based on hydrogen gas concentration changes and signal rate-of-change analysis.

  2. Flatus Per Hour

    Time frame: 12 hours each day for 3 days

    The rate of flatus events normalized per hour, calculated from the total number of events and the total monitored time.

  3. Microbiome Activity Index Comparative Score

    Time frame: 12 hours each day for 3 days

    A relative score comparing the participant's Microbiome Activity Index to aggregated anonymized results from other individuals in the Human Flatus Atlas study. Presented as a percentile rank or standardized score.

  4. Fiber-Normalized Flatus Frequency

    Time frame: 12 hours each day for 3 days

    The participant's flatus frequency (events/day) normalized by self-reported dietary fiber intake (grams/day). Normalization will allow assessment of typical adult flatulence frequency in relation to fiber consumption.

Study contacts

Contact information is provided by the study sponsor or research team.

Brantley Hall, PhD

CONTACT

[email protected]

5407978040

Sponsors and collaborators

Lead sponsor

University of Maryland, College Park

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 21, 2025
Registry last updated
Dec 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.